- Corporate Officers - W
- Wiggans Thomas G
Insider Trading History of Wiggans Thomas G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wiggans Thomas G since 2006.
This trader's CIK number is 1208907.
At the time of last reporting, Wiggans Thomas G was the Officer of Jasper Therapeutics, Inc.. (stock ticker symbol JSPR).
Also see all insider trading activities at Jasper Therapeutics, Inc..
Note that in the past
WIGGANS THOMAS G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Dermira, Inc. (DERM) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | DERM | 23,419 | $199,998 | 0 | $0 | 25,500 | $0 |
2018 | DERM | 49,805 | $479,489 | 0 | $0 | 30,500 | $9,860 |
2017 | DERM | 0 | $0 | 79,000 | $2,439,052 | 96,000 | $83,983 |
2016 | DERM | 0 | $0 | 113,000 | $3,430,960 | 3,000 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | SOMX | 0 | $0 | 30,163 | $80,927 | 0 | $0 |
Yearly summary of insider trading at Connetics Corp (CNCT) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | CNCT | 10,000 | $107,304 | 8,000 | $122,420 | 18,000 | $82,116 |
Yearly summary of insider trading at Peplin Inc (PLI) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | PLI | 500 | $5,000 | 0 | $0 | 0 | $0 |
2008 | PLI | 1,000 | $4,973 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Onyx Pharmaceuticals Inc (ONXX) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ONXX | 0 | $0 | 15,200 | $1,283,970 | 14,000 | $364,102 |
2012 | ONXX | 0 | $0 | 12,000 | $823,415 | 10,000 | $253,000 |
2007 | ONXX | 1,000 | $38,671 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pardes Biosciences, Inc. (PRDS) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | PRDS | 37,500 | $39,375 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Jasper Therapeutics, Inc. (JSPR) by Wiggans Thomas G
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | JSPR | 40,000 | $24,630 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Wiggans Thomas G:
1. Dermira, Inc. (DERM)
2. Somaxon Pharmaceuticals, Inc. (SOMX)
3. Connetics Corp (CNCT)
4. Peplin Inc (PLI)
5. Onyx Pharmaceuticals Inc (ONXX)
6. Pardes Biosciences, Inc. (PRDS)
7. Jasper Therapeutics, Inc. (JSPR)
Table 1. Insider trading of Dermira, Inc. (DERM) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-08-19 | DERM | Buy | 23,419 | 8.54 | 199,998 |
2019-08-15 | DERM | Option Ex | 25,500 | .00 | 0 |
2018-08-15 | DERM | Option Ex | 20,500 | .00 | 0 |
2018-07-09 | DERM | Buy | 12,000 | 10.00 | 119,952 |
2018-07-02 | DERM | Buy | 13,780 | 8.71 | 119,996 |
2018-06-25 | DERM | Buy | 12,150 | 9.84 | 119,592 |
2018-06-18 | DERM | Buy | 11,875 | 10.10 | 119,949 |
2018-05-15 | DERM | Option Ex | 10,000 | .99 | 9,860 |
2017-12-21 | DERM | Option Ex | 5,000 | 1.22 | 6,090 |
2017-12-13 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-12-13 | DERM | Sale | 5,000 | 27.51 | 137,565 |
2017-11-02 | DERM | Sale | 5,000 | 27.52 | 137,610 |
2017-11-02 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-10-10 | DERM | Sale | 5,000 | 27.52 | 137,605 |
2017-10-10 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-09-18 | DERM | Sale | 9,500 | 27.51 | 261,335 |
2017-09-18 | DERM | Option Ex | 9,500 | .99 | 9,367 |
2017-08-15 | DERM | Option Ex | 12,000 | .00 | 0 |
2017-08-01 | DERM | Sale | 500 | 27.58 | 13,790 |
2017-08-01 | DERM | Option Ex | 500 | .99 | 493 |
2017-07-03 | DERM | Sale | 5,000 | 29.06 | 145,300 |
2017-07-03 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-06-01 | DERM | Option Ex | 3,879 | .99 | 3,824 |
2017-06-02 | DERM | Option Ex | 1,121 | .99 | 1,105 |
2017-06-01 | DERM | Sale | 3,879 | 27.50 | 106,672 |
2017-06-02 | DERM | Sale | 1,121 | 27.61 | 30,950 |
2017-05-01 | DERM | Sale | 8,000 | 34.02 | 272,160 |
2017-05-01 | DERM | Option Ex | 8,000 | .99 | 7,888 |
2017-04-03 | DERM | Sale | 8,000 | 33.70 | 269,632 |
2017-04-03 | DERM | Option Ex | 8,000 | .99 | 7,888 |
2017-03-03 | DERM | Option Ex | 4,000 | .99 | 3,944 |
2017-03-03 | DERM | Sale | 4,000 | 37.60 | 150,416 |
2017-03-01 | DERM | Option Ex | 11,000 | .99 | 10,846 |
2017-03-01 | DERM | Sale | 11,000 | 34.48 | 379,225 |
2017-02-01 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-02-01 | DERM | Sale | 5,000 | 29.66 | 148,290 |
2017-01-03 | DERM | Option Ex | 5,000 | .99 | 4,930 |
2017-01-04 | DERM | Option Ex | 3,000 | .99 | 2,958 |
2017-01-03 | DERM | Sale | 5,000 | 30.19 | 150,960 |
2017-01-04 | DERM | Sale | 3,000 | 32.51 | 97,542 |
2016-12-01 | DERM | Sale | 11,000 | 31.04 | 341,385 |
2016-11-01 | DERM | Sale | 11,000 | 31.19 | 343,090 |
2016-10-03 | DERM | Sale | 11,000 | 34.70 | 381,700 |
2016-09-01 | DERM | Sale | 11,000 | 31.30 | 344,355 |
2016-08-15 | DERM | Option Ex | 3,000 | .00 | 0 |
2016-08-01 | DERM | Sale | 11,000 | 32.91 | 362,065 |
2016-07-05 | DERM | Sale | 2,000 | 30.18 | 60,360 |
2016-07-01 | DERM | Sale | 9,000 | 29.49 | 265,410 |
2016-06-01 | DERM | Sale | 11,000 | 31.34 | 344,795 |
2016-05-02 | DERM | Sale | 9,000 | 25.11 | 225,990 |
2016-04-01 | DERM | Sale | 7,000 | 20.69 | 144,830 |
2016-02-01 | DERM | Sale | 9,000 | 27.56 | 248,040 |
2016-01-04 | DERM | Sale | 11,000 | 33.54 | 368,940 |
Table 2. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-12-01 | SOMX | Sale | 30,163 | 2.68 | 80,927 |
Table 3. Insider trading of Connetics Corp (CNCT) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-10-02 | CNCT | Buy | 4,000 | 10.75 | 43,000 |
2006-09-21 | CNCT | Buy | 2,000 | 10.64 | 21,278 |
2006-09-19 | CNCT | Buy | 2,000 | 10.31 | 20,626 |
2006-09-20 | CNCT | Buy | 2,000 | 11.20 | 22,400 |
2006-05-31 | CNCT | Option Ex | 12,000 | 4.56 | 54,744 |
2006-03-01 | CNCT | Option Ex | 4,000 | 4.56 | 18,248 |
2006-03-01 | CNCT | Sale | 4,000 | 16.06 | 64,244 |
2006-01-13 | CNCT | Option Ex | 2,000 | 4.56 | 9,124 |
2006-01-13 | CNCT | Sale | 4,000 | 14.54 | 58,176 |
Table 4. Insider trading of Peplin Inc (PLI) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-01-14 | PLI | Buy | 500 | 10.00 | 5,000 |
2008-11-19 | PLI | Buy | 500 | 3.95 | 1,973 |
2008-11-10 | PLI | Buy | 500 | 6.00 | 3,000 |
Table 5. Insider trading of Onyx Pharmaceuticals Inc (ONXX) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-05-06 | ONXX | Option Ex | 4,500 | 26.46 | 119,092 |
2013-05-06 | ONXX | Sale | 4,500 | 91.01 | 409,545 |
2013-04-05 | ONXX | Option Ex | 2,500 | 25.30 | 63,250 |
2013-04-05 | ONXX | Sale | 3,700 | 86.00 | 318,200 |
2013-03-08 | ONXX | Sale | 2,000 | 85.00 | 170,000 |
2013-03-08 | ONXX | Option Ex | 2,000 | 27.63 | 55,260 |
2013-03-05 | ONXX | Option Ex | 2,500 | 25.30 | 63,250 |
2013-03-05 | ONXX | Sale | 2,500 | 77.20 | 193,000 |
2013-02-05 | ONXX | Option Ex | 2,500 | 25.30 | 63,250 |
2013-02-05 | ONXX | Sale | 2,500 | 77.29 | 193,225 |
2012-08-16 | ONXX | Sale | 12,000 | 68.62 | 823,415 |
2012-08-16 | ONXX | Option Ex | 10,000 | 25.30 | 253,000 |
2007-08-29 | ONXX | Buy | 1,000 | 38.67 | 38,671 |
Table 6. Insider trading of Pardes Biosciences, Inc. (PRDS) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-12-02 | PRDS | Buy | 12,500 | 1.07 | 13,375 |
2022-12-01 | PRDS | Buy | 25,000 | 1.04 | 26,000 |
Table 7. Insider trading of Jasper Therapeutics, Inc. (JSPR) by Wiggans Thomas G
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-11-21 | JSPR | Buy | 10,000 | .64 | 6,380 |
2023-11-20 | JSPR | Buy | 10,000 | .63 | 6,310 |
2023-11-16 | JSPR | Buy | 10,000 | .60 | 5,970 |
2023-11-17 | JSPR | Buy | 10,000 | .60 | 5,970 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wiggans Thomas G
(Officer of Jasper Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.